μ Opioid Modulation of Sensorimotor Functional Connectivity in Autism: Insights From a Pharmacological Neuroimaging Investigation Using Tianeptine

Our findings suggest that μ opioid neurosignaling may contribute to functional brain differences in the sensorimotor network in autism. Given that sensorimotor system alterations are thought to be central to autism and contribute to other core autistic features, as well as adaptability and mental health, further research is warranted to explore the translational potential of μ opioid modulation in autism.

Authors

Institutions

Publication Details

Journal
Biological Psychiatry Global Open Science
Published
2025-12-04
DOI
https://doi.org/10.1016/j.bpsgos.2025.100663
Primary Topic
Autism Spectrum Disorder Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

μ Opioid Modulation of Sensorimotor Functional Connectivity in Autism: Insights From a Pharmacological Neuroimaging Investigation Using Tianeptine

Robert Wichers, Nichol M. L. Wong, Jason He, Vladimira Stoencheva et al.
Biological Psychiatry Global Open Science
Autism Spectrum Disorder Research
article

μ Opioid Modulation of Sensorimotor Functional Connectivity in Autism: Insights From a Pharmacological Neuroimaging Investigation Using Tianeptine

Robert Wichers, Nichol M. L. Wong, Jason He, Vladimira Stoencheva, Glynis Ivin, Sydney Leaman, Lucas G. S. França, Declan Murphy, Gráinne McAlonan, Dafnis Batallé, Sarah Blainey, James L. Findon, Mihail Dimitrov, Eileen Daly, Štefan Holiga, Mark D. Tricklebank, David J. Lythgoe, Dene Robertson, Ioannis Valasakis
article en

Abstract

Our findings suggest that μ opioid neurosignaling may contribute to functional brain differences in the sensorimotor network in autism. Given that sensorimotor system alterations are thought to be central to autism and contribute to other core autistic features, as well as adaptability and mental health, further research is warranted to explore the translational potential of μ opioid modulation in autism.

Biological Psychiatry Global Open ScienceVol. 6(2)
Roche (Switzerland) (CH), Deakin University (AU), King's College London (GB), South London and Maudsley NHS Foundation Trust (GB), Northumbria University (GB), Education University of Hong Kong (HK), Amsterdam Neuroscience (NL), King's College School (GB), Medical Research Council (GB)
Autism Speaks, F. Hoffmann-La Roche, South London and Maudsley NHS Foundation Trust, Northumbria University, European Federation of Pharmaceutical Industries and Associations, LGS Foundation, Simons Foundation Autism Research Initiative, Amsterdam University Medical Centers, National Institute for Health and Care Research, Department of Health and Social Care, King's College London, European Commission, Deakin University, Education University of Hong Kong, Medical Research Council Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, NIHR Maudsley Biomedical Research Centre, Medical Research Council, Menzies Centre for Australian Studies, King's College London, University of London, Division of Materials Research
Openalex Percentile: Top 61%
Autism Spectrum Disorder Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.